Introduction to Psoriasis Introduction to Psoriasis
FDA Experience: Topical Corticosteroids and HPA Axis Suppression
Joint NDAC/DODAC Advisory Committee Meeting March 24, 2005 Rx Topical Corticosteroids and Testing for Adrenal Suppression Markham C. Luke, M.D., Ph.D.
Pediatric Subcommittee of the AIDAC October 29-30, 2003 Topical Immunosuppressants Bindi M. Nikhar, M.D., FAAP Division of Dermatologic and Dental Drug.
Pediatric Subcommittee Presentation on Pharmacologic Control of Drooling John V. Kelsey, D.D.S. Lisa Mathis M.D. Division of Dermatologic and Dental Drug.
